ྫ࿪೧ౕɻ৿‫׃‬୉ָ೶‫ڠॶڂݜ‬ಋཤ༽ʀ‫ڠ‬ಋ‫ं୔ࡀڂݜ‬Ҳལ՟ୌ൬ߺ‫ڠ‬ಋ‫ڂݜ‬झพ৿‫و‬‫ڂݜ‬େනं‫ڂݜ‬՟ୌ໌‫ܩ‬କνΤΨϏοʖ͕͜Ζքഇ༟པαϨϱࡠಊ੓ਈ‫ܻ࢙ܨ‬Ϙϕοχ‫ؖ‬࿊ϕϫζΥέφ‫و৿ ܗ‬ϕϫζΥέφ‫ و৿ ܗ‬౹߻ࣨ௒঳Ϡυϩಊ෼Ν༽͏ͪ‫ݮ‬௎͹ਈ‫خܨ‬൭Ͷ‫ͤؖ‬Ζ‫ڂݜ‬ϕϫζΥέφ‫و৿ ܗ‬ϕϫζΥέφ‫و৿ ܗ‬ϕϫζΥέφ‫و৿ ܗ‬ॶ଒৮໌ॶ಼ଲԢ‫گ‬ҽࢱ໌෾໼໌ࢱ໌໌‫ݻ‬Բࢤཱི୉ָ‫گ‬दনઔɻଉ೯Ҫఽࢢ‫ؽ‬೵մੵָ෾໼ஓ಼ɻ݊‫ۿ‬ຌ୉ָ‫گ‬द૛ɻชᐤ෾ࢢਈ‫ܨ‬ਫ਼෼ָ෾໼಻ഀɻ޼೯෨ௗ੗ɻඔ಺ࢢබཀྵָ෾໼֡ీɻ໎ඔҏྜྷ୉ָ‫گ‬दో෨ɻ࿪ඛබཀྵָ෾໼֡ీɻ໎ඔ๼քಕ୉ָබӅঁ‫گ‬ੁࢃɻ୕೶‫ؽ‬೵մੵָ෾໼নᖔɻ౵ϕϫζΥέφ‫಼ و৿ ܗ‬Ҿదߨಊ͹ਈ‫خܨ‬൭͹մ໎஦‫ښ‬୉ָ೜‫غ‬੏ߪࢥ ठଡɻุഀ౹߻೶‫ؽ‬೵‫ڂݜ‬ιϱνʖґ౽ɻߔղϕϫζΥέφ‫͏͢৿ و৿ ܗ‬ϓΥϫφʖεη૏֒εητϞͶΓΖਈ‫ࡋܨ‬๖ฯ‫ޤ‬͹‫ݗ‬౾‫܊‬ഇ୉ָ‫گ‬द௙‫ڋ‬ɻ੒࢚ਈ‫಼ܨ‬Ռָ෾໼ۜᖔɻկਕϕϫζΥέφ‫ و৿ ܗ‬ອ੓仑௩‫ؖ‬࿊෾ࢢΝඬదͳͪ͢೶͕Γ;੺ਹͲ͹‫ؽ‬೵దմ໎‫ؖ‬੤ҫՌ୉ָ०‫گ‬दฤ໼ɻ଻େϠυϩಊ෼֋൅෾໼Ѫ෨ɻָϕϫζΥέφ‫و৿ ܗ‬ਈ‫ܨ‬෨ௗෳଡɻਇ࢛೶ਈ‫֐ܨ‬Ռ෾໼౽Ҭɻ߀ඛϕϫζΥέφ‫ و৿ ܗ‬ඏঘ؇݃߻νϱϏέ࣯Ν஦ৼͳͪ͢ΰόϞմੵͳ‫ؽ‬೵մੵಋࢦऀ୉ָਫ਼ໍҫՌָ෨०‫گ‬द‫ࡖٸ‬ɻஎ޼Ҫఽࢢ‫ؽ‬೵մੵָ෾໼‫ٸ‬ԾɻఫఱϕϫζΥέφ‫ و৿ ܗ‬ਈ‫ܨ‬յ࿑੠៝ԿϟΩωθϞ͹ҪఽָదմੵࠅཱིҪఽָ‫ॶڂݜ‬‫گ‬द‫཮آ‬ɻ୘࣑ಊ෼ࣁ‫֋ݱ‬൅‫ڂݜ‬෾໼࡭Ԯɻय़๞౨‫ښ‬୉ָঁ‫گ‬ࢃీɻ‫܈‬ਫ਼ରࣕ‫ڠـ‬໒ָ෾໼‫ޔ‬ॉཞɻദ஦ޮཱི୉ָ๑ਕԥශࢤཱི୉ָ०‫گ‬दౖҬɻ޼ಊ෼ࣁ‫֋ݱ‬൅‫ڂݜ‬෾໼࡭Ԯɻय़๞‫ڂݜ‬ҽ߶ಌɻ༡ฑ೶ਈ‫಼ܨ‬Ռָ෾໼ۜᖔɻկਕ‫گ‬दনӞɻߌ༺බཀྵָ෾໼֡ీɻ໎ඔ‫گ‬दోวɻկඛϠυϩಊ෼֋൅෾໼Ѫ෨ɻָ౨‫ښ‬ҫՌࣅՌ୉ָঁ‫گ‬ෲ෨ɻ߶໎೶‫ؽ‬೵մੵָ෾໼নᖔɻ౵ࠅཱིௗथҫྏ‫ڂݜ‬ιϱνʖ෨ௗඎ࡜ɻߔҲҪఽࢢ‫ؽ‬೵մੵָ෾໼‫ٸ‬Ծɻఫఱ౽ీҫՌ୉ָ‫گ‬दྵ໨ɻ‫ݫ‬ಊ෼ࣁ‫֋ݱ‬൅‫ڂݜ‬෾໼࡭Ԯɻय़๞ࠅཱི१‫ح؂‬බ‫ڂݜ‬ιϱνʖ෨ௗஶ‫ݬ‬ɻ‫࢛ڣ‬ਈ‫಼ܨ‬Ռָ෾໼ঘ໼࣋ɻཀྵ ϕϫζΥέφ‫ܩ ܗ‬କ *$%$ՀઈͶ‫ͪ͏Ͱخ‬౹߻ࣨ௒঳Ϡυϩϧρφ͹බସմੵ‫܊‬ഇ୉ָ‫گ‬द༆ઔɻӊએ෋෾ࢢਈ‫ܨ‬ਫ਼෼ָ෾໼಻ഀɻ޼೯ ϕϫζΥέφ‫ܩ ܗ‬କ ߶ࣕ৖05,Ν༽͏ͪ൅ୣ্֒Ͷ൒͑౹߻ద೶‫ؽ‬೵Ͷ‫ͤؖ‬Ζ‫ڂݜ‬ࠅཱི੔үҫྏ‫ڂݜ‬ιϱνʖঘࢮɻୣ໷౹߻೶‫ؽ‬೵‫ڂݜ‬ιϱνʖྵ໨ɻ༦࣑෨ௗṦ޳ɻਇਕ೶࣮‫׳‬ඬຌࣁ‫ݱ‬մੵָ෾໼֡ీɻ໎ඔ๼཮୉ָ०‫گ‬द൚૖ɻ੥ಊ෼ࣁ‫֋ݱ‬൅‫ڂݜ‬෾໼࡭Ԯɻय़๞߄઴୉ָঁ‫گ‬୰࣑ɻ๞࿪බཀྵָ෾໼֡ీɻ໎ඔ࣐ծҫՌ୉ָ‫گ‬द੤ଞɻਜ਼धҪఽࢢ‫ؽ‬೵մੵָ෾໼ஓ಼ɻ݊٢ஏɻਜ਼ཾҪఽࢢ‫ؽ‬೵մੵָ෾໼‫ٸ‬ԾɻఫఱҾࢢ͹ಊସΠϩςύ΢Ϝʖබ೶Ͷ͕͜ΖΠϝϫηϓΥϫ΢χ‫ܙ‬੔ͳਈ‫ࡋܨ‬๖ޮӻࡔ஄๑ਕਈ‫ރ‬ҫྏࢊ‫ۂ‬্֒͹࣎‫ؔۯ‬దմੵ౐ࢤਬ਒‫ߑؽ‬‫۔‬Ҧक़੓ଈࡩߙԿ঳ $/6 ࡋ๖࣯7'3‫ॄڿ‬ର‫ܙ‬੔Νཊ੏ͤΖ෾ࢢ͹ಋఈͳ‫ؽ‬೵մੵघढ़҈સͳ‫گ‬үΝ໪దͳͪ͢਄૜ָसͶΓΖ‫ݨ‬ඏ‫ں‬घढ़ӫ଀մੵ‫ڂݜ‬ଈಆཁͱΞ͖ΞͶ͕͜ΖͱΞ͖Ξ঱఼͹ՆࢻԿʖPXOWLPRGDOLW\Ν ࠅཱིබӅ‫ߑؽ‬੤৿‫׃‬஦ԟබ༽͏ͪढ़઴඲ՃͶΓΖ֐Ռघढ़͹੔੹޴৏Ͷ޴͜ͱʖΠϩςύ΢ϜʖබνΤட੷͕Γ;ร੓ͶଲͤΖDTXDSRULQ‫ؽ‬೵ଇϕϫζΥέφ‫و৿ ܗ‬ϕϫζΥέφ‫ و৿ ܗ‬6&$ϠυϩϜΤηմੵΝ௪ͣͪ੺ਹঘ೶ร੓঳࣑ྏ๑͹֋൅

਒༂7*1͹ްՎ͹‫ৄݗ‬ϕϫζΥέφ‫ و৿ ܗ‬ϝέϫήϨΠ‫ؽ‬೵र২ͶΓΖνΤබସ͹รԿ͹‫ݗ‬౾ϕϫζΥέφ‫ و৿ ܗ‬೶ਈ‫׳࣮ܨ‬Ͷ͕͜Ζಖ‫ࡑۃ‬͹εϱέϫφϫϱ๎ࣻޭͶΓΖմੵϕϫζΥέφ‫و৿ ܗ‬ ϕϫζΥέφ‫ܩ ܗ‬କ ϕϫζΥέφ‫ܩ ܗ‬କӅϜϩοϠʖξϩ͵೶ժ଀ͳ೶‫ؽ‬೵υʖνΝ༽͏ͪϜϩοϠʖξϩ‫ؽ‬փָस([SHULPHQWDODXWRLPPXQHHQFHSKDORP\HOLWLVϜΤη͹ࡠ੔͕Γ;ͨΗΝ༽͏࣑ͪྏ๑֋൅Ҫఽ੓೶ঘ݄؇බϠυϩಊ෼Ν༽͏ͪ೶ଖ஦ʀ೟எ঳͹৿‫ྏ࣑و‬๑͹֋൅εϊέϪ΢όϏοʖͶ͕͜Ζҡ৙ட੷νϱϏέ࣯͹ഋड़ထ਒ͳ࣑ྏ๑͹֋൅݄ᕸ஦,/(,ఈྖͶΓΖ߶ྺं೟எ‫ؽ‬೵্֒͹ॵ‫غ‬γϫΰ΢φϜʖΩʖͳ͢ͱ͹‫ৄݗ‬ ϕϫζΥέφ‫ܩ ܗ‬କ Πϩςύ΢ϜʖබͶ‫ؖ‬࿊ͤΖΰόϞ৚ๅΝۨ࢘ͪ͢ଡҪఽࢢմੵ ϕϫζΥέφ‫ܩ ܗ‬କ౽ీҫՌ୉ָ๼քಕ୉ָ୉ָӅҫָ‫ڂݜ‬ ϕϫζΥέφ‫ܩ ܗ‬କ ηφϪηԢ౶Ͷ͕͜ΖχʖϏϝϱण༲ର͹ༀׄ͹մ໎ ϕϫζΥέφ‫ܩ ܗ‬କߑʀ๎ࣻતҫָ૱߻‫ॶڂݜ‬୔దյ࿑‫ܙ‬੔‫ߑؽ‬ ϕϫζΥέφ‫ܩ ܗ‬କ νΤΨϏοʖබཀྵૌ৭ඬຌΝ༽͏ͪνΤ3(7ժ଀බཀྵ૮‫ؖ‬մੵ ϕϫζΥέφ‫ܩ ܗ‬କྖࢢՌָٗढ़‫֋ڂݜ‬൅‫ؽ‬೶ྌ๴୉‫ޛ‬ൿ࣯Ͷ͕͜Ζήϩνϝϱ࢐ण༲ର*OX'ͶΓΖ೘ྙમ ϕϫζΥέφ‫ܩ ܗ‬କ ೟எ঳͹մ໎ͳ੠ືҫྏࣰ‫ݳ‬Ν໪దͳͪ͢ΰόϞΨϝέηմੵ ϕϫζΥέφ‫ܩ ܗ‬କӅ೶ਈ‫֐ܨ‬ՌྡজԢ༽ͶࣁͤΖ>&@7*1͹ਟଐ͖ͯ߶फྖ͵੣ଆ߻੔๑ྖࢢՌָٗढ़‫֋ڂݜ‬൅‫ؽ‬ߑʀ๎ࣻતҫָ૱߻‫ॶڂݜ‬୉ࡗ୉ָ෯Ӆௗʀ౹‫ׇ‬෨ௗಝ೜ߪࢥ ৙‫ۊ‬ෳౣ‫ཱིݟ‬ҫՌ୉ָ‫گ‬द‫ٳ‬ฯɻ‫ۋ‬ਫ਼ରࣕ‫ڠـ‬໒ָ෾໼‫ޔ‬ॉཞɻദ஦৶य୉ָಝ೜‫گ‬दঘ༆ɻੜޭබཀྵָ෾໼֡ీɻ໎ඔ ϕϫζΥέφ‫ܩ ܗ‬କ ೶༟པ͹݄஦౸νϱϏέ࣯͹໤དద͵ಋఈ๏๑͹ཱི֮‫ؖ‬੤ҫՌ୉ָ०‫گ‬द੼ؔɻஒ໷Ϡυϩಊ෼֋൅෾໼Ѫ෨ɻָ ϕϫζΥέφ‫ܩ ܗ‬କ ਯເְ੩ͳ‫ى‬Գ੏‫ޜ‬Ͷ‫ؖ‬ΚΖࢻজԾ෨ਈ‫ܨ‬͹ಊࡠ‫ݬ‬ཀྵմ໎໌‫ݻ‬Բ୉ָ‫گ‬दࢃ஦ɻহ߄ಊ෼ࣁ‫֋ݱ‬൅‫ڂݜ‬෾໼࡭Ԯɻय़๞०‫گ‬दᅵҬɻ଻ਕබཀྵָ෾໼֡ీɻ໎ඔঁ‫گ‬எ‫ݡ‬ɻ૳ඔಊ෼ࣁ‫֋ݱ‬൅‫ڂݜ‬෾໼࡭Ԯɻय़๞ঁ‫گ‬੃୫ɻ༐धϠυϩಊ෼֋൅෾໼Ѫ෨ɻָঁ‫گ‬নຌɻ৶ӵබཀྵָ෾໼֡ీɻ໎ඔ ϕϫζΥέφ‫ܩ ܗ‬କ͹֋൅ਈ‫ܨ‬ร੓࣮‫׳‬ಝҡ஁പͳਈ‫ࡋܨ‬๖୦ཚʁϐφ‫خ‬ఊ֫Ͷ͕͜Ζఈྖద‫ݗ‬౾ ϕϫζΥέφ‫ܩ ܗ‬କ ੠ਈ࣮‫ޛࢰ׳‬೶͹෾ࢢϕϫϓΟ΢ϩմੵ ϕϫζΥέφ‫ܩ ܗ‬କ ҪఽࢢրรϜΤηΝ༽͏ͪ୉೶‫خ‬ఊ࣮֫‫׳‬͹බସਫ਼ཀྵ͹մੵ ϕϫζΥέφ‫ܩ ܗ‬କࣅয়յᰔཽࡋ๖͹‫ڷ‬ฅ੓ͶଲͤΖGLDF\OJO\FHUROOLSDVHDOSKD͹ༀׄ͹մ໎ ϕϫζΥέφ‫ܩ ܗ‬କ νΤ‫ॄڿ‬ର͹ఽ೽Ͷ͕͜ΖϝέϫήϨΠ͹ༀׄෳౣ‫ཱིݟ‬ҫՌ୉ָճ௣ҫྏιϱνʖࣙષՌָ‫ߑؽڂݜ‬ɻਫ਼ཀྵָ‫ॶڂݜ‬౨‫ښ‬୉ָࣝࣉౣ୉ָҫࣅָ૱߻‫ڂݜ‬Ռ ϕϫζΥέφ‫ܩ ܗ‬କ Ҫఽࢢրรٗढ़ͶΓΖਫ਼ରϨθϞ஦਽͹෾ࢢ‫ߑؽ‬͹մੵ ϕϫζΥέφ‫ܩ ܗ‬କ‫౐ښ‬୉ָಝ೜‫گ‬दԮଞɻ‫ۋ‬ಊ෼ࣁ‫֋ݱ‬൅‫ڂݜ‬෾໼࡭Ԯɻय़๞ೖຌҫՌ୉ָ୉ָӅ०‫گ‬द੤ࢃɻ߃༡౹߻೶‫ؽ‬೵‫ڂݜ‬ιϱνʖ‫ޔ‬ॉཞɻദ஦‫ز‬෠༂Ռ୉ָ‫گ‬दฯेɻޯබཀྵָ෾໼֡ీɻ໎ඔҫௗӕҬɻ௜‫ܡ‬౹߻೶‫ؽ‬೵‫ڂݜ‬ιϱνʖྵ໨ɻ༦࣑‫ཻٳ‬ธ୉ָ‫گ‬दੁీɻฯ༦බཀྵָ෾໼֡ీɻ໎ඔ௔ย‫ۅ‬ఁ෾ࢢԿ߻෼͹ਫ਼ରφϪʖγʖͳ͢ͱ͹Ԣ༽Ν໪ࢨͪ͢‫خ‬ྖࢢՌָٗढ़‫֋ڂݜ‬൅‫ؽ‬οʖϞϨʖે‫ݗ‬౾ߑʀ๎ࣻતҫָ૱߻‫ॶڂݜ‬ξʖ੪໨ɻґஎ஋ਫ਼ରࣕ‫ڠـ‬໒ָ෾໼‫ޔ‬ॉཞɻദ஦1)N%‫׈‬੓ԿΝඬదͳͪ͢஦਽ਈ‫ݬܨ‬൅ѳ੓ϨϱϏञ࣑ྏ๑͹֋ԥශࢤཱི୉ָ୉ָӅҫָ‫ݜ‬൅Ͷ޴ͪ͜ଡࢬઅ‫ڠ‬ಋ‫ڂݜ‬‫ڂ‬Ռঁ‫گ‬ཱི੶ɻ݊༠೶ਈ‫֐ܨ‬Ռָ෾໼౽Ҭɻ߀ඛ०‫گ‬द஦ౣɻԃҪఽࢢ‫ؽ‬೵մੵָ෾໼ஓ಼ɻ݊ঁ‫گ‬ۛ౽ɻՈࢢ೶ਈ‫֐ܨ‬Ռָ෾໼ᑪీɻָ୉ࡗҫՌ୉ָ‫ٮ‬ҽ‫گ‬दґ౽ɻ੥್Ҫఽࢢ‫ؽ‬೵մੵָ෾໼ஓ಼ɻ݊໌‫ݻ‬Բࢤཱི୉ָ‫گ‬द੼௣ɻ༡߃Ҫఽࢢ‫ؽ‬೵մੵָ෾໼‫ٸ‬Ծɻఫఱ‫ڂݜ‬ҽ߶ಌɻ༡ฑබཀྵָ෾໼ੜਭɻ޼ௐ಼ࡋۗ૕͕Γ;ௐ؇৏ൿࡋ๖͖Δ͹'$03V੏‫ޜ‬ͶΓΖ೶‫݄ڑ‬බ૧਒ఴ΃͹Ӫ‫ڻ‬ ϕϫζΥέφ‫ܩ ܗ‬କ ‫ݿ‬൅੓$/6‫ݡͲं׳‬ड़͠Ηͪ৿‫و‬PLFUR51$͹‫ؽ‬೵մੵϕϫζΥέφ‫ܩ ܗ‬କϕϫζΥέφ‫ܩ ܗ‬କϕϫζΥέφ‫ܩ ܗ‬କϕϫζΥέφ‫ܩ ܗ‬କϕϫζΥέφ‫ܩ ܗ‬କϕϫζΥέφ‫ܩ ܗ‬କϕϫζΥέφ‫ܩ ܗ‬କϕϫζΥέφ‫ܩ ܗ‬କ߶ࣕ৖05,Ν༽͏ͪͱΞ͖Ξ‫ݬ‬੓෨Ғ‫ؽ;ٶ‬೵෨Ғͳ͹‫ܐؖ‬͹‫ݜ‬੫ԮͱΞ͖Ξʀਈ‫ܨ‬ҫྏι‫ڂ‬ϱνʖ஦਽ਈ‫ݬܨ‬൅ѳ੓ϨϱϏञͶ͕͜Ζ7$&&൅‫ͨͳݳ‬͹ྡজබཀྵָదқٝಝ൅੓ਜ਼৙ѻਭಆ঳‫ं׳‬೶੺ਹӹ஦͹ώ΢ΨϜʖΩʖਏஇͳ॑঳ౕ෾ྪ͹ཱི֮ॳళಌ୉ָ

%RURQQHXWURQFDSWXUHWKHUDS\ %1&7 ͗೽झʀਃ७Ͷ‫ްͤ·ٶ‬‫౐ښ‬୉ָ෵߻‫ྙࢢݬ‬Ռָ‫ݜ‬Վ͹‫ݗ‬౾‫ॶڂ‬51$6HTմੵΝ༽͏Ζ͗Ξ੓仑௩ͳೋ࣑੓ਈ‫্֒ܨ‬੓仑௩Ͷ‫ؖ‬࿊෾ࢢ͹୵ࡩʀಋఈ೟எ঳‫ؖ‬࿊࣮‫׳‬ϨηέҪఽࢢʤಝͶ$&($%&$ɼ)86Ͷ‫ͱؖ͢‬ʥ‫ࡩݗ‬ϕϫζΥέφ‫ܩ ܗ‬କ ‫ک۔‬௜੓ζηφϫϓΡʖͶ͕͜ΖνΤබร͹඲Ճˠॶ଒͕Γ;৮໌ͺਅ੧࣎͹΍͹ͲͤɽྖࢢՌָٗढ़‫֋ڂݜ‬൅‫ؽ‬ߑʀ๎ࣻતҫָ૱߻‫ॶڂݜ‬ྫ࿪೧ౕɻ৿‫׃‬୉ָ೶‫ڠॶڂݜ‬ಋཤ༽ʀ‫ڠ‬ಋ‫ं୔ࡀڂݜ‬Ҳལ՟ୌ൬ߺ‫ڠ‬ಋ‫ڂݜ‬झพ৿‫و‬࿊‫ݱࣁܠ‬ཤ༽‫و৿ ܗ‬೶‫ڂݜ‬Ͷචਤ͵ҪఽࢢրรϜΤη͹‫ܧ‬౹ฯଚͶ॑གྷ͵ക཈ড়݇͹ॶ಼ଲԢ‫گ‬ҽ‫ڂݜ‬େනं‫ڂݜ‬՟ୌ໌‫ܩ‬କॶ଒৮໌ࢱ໌෾໼໌ࢱ໌౨‫ښ‬ҫՌ୉ָ‫گ‬द‫࣌ٳ‬ɻ௜দಊ෼ࣁ‫֋ݱ‬൅‫ڂݜ‬෾໼࡭Ԯɻय़๞࿊‫ݱࣁܠ‬ཤ༽‫ و৿ ܗ‬ਈ‫ܨ‬ร੓࣮‫׳‬ϠυϩϜΤη͹ϐφ࣮‫ͳ׳‬͹࿊‫ؖ‬দ࿪୉ָ०‫گ‬द୉୎ɻദ࿪බཀྵָ෾໼֡ీɻ໎ඔ࿊‫ݱࣁܠ‬ཤ༽‫ و৿ ܗ‬౹߻ࣨ௒঳Ϡυϩδϩ͹೶බཀྵָదรԿ͹‫ڂݜ‬‫౐ښ‬୉ָྸௗྪ‫ॶڂݜ‬‫گ‬द஦ଞɻࠂधබཀྵָ෾໼֡ీɻ໎ඔ࿊‫ݱࣁܠ‬ཤ༽‫و৿ ܗ‬౨‫ښ‬୉ָ०‫گ‬दఖɻ‫ٳ‬ඔࢢ೶ਈ‫֐ܨ‬Ռָ෾໼౽Ҭɻ߀ඛ࿊‫ݱࣁܠ‬ཤ༽‫׳࣮ و৿ ܗ‬Ϡυϩಊ෼͹ࡠ੣ɼฯଚɼൡ৫Ͷ‫ͤؖ‬Ζ࠹઎୼ٗढ़͹֋൅‫ۿ‬ຌ୉ָߪࢥ஝ඎɻಃಊ෼ࣁ‫֋ݱ‬൅‫ڂݜ‬෾໼࡭Ԯɻय़๞࿊‫ݱࣁܠ‬ཤ༽‫۔ و৿ ܗ‬Ҧक़੓ଈࡩߙԿ঳Ͷ͕͜Ζ΢όεφʖϩϨϱ࢐Ϋψʖκ͹ༀׄ ౨ք୉ָҫָ෨‫گ‬दӮీɻӭҲ࿢බཀྵָ෾໼֡ీɻ໎ඔ࿊‫ݱࣁܠ‬ཤ༽‫و৿ ܗ‬ಝ೜०‫گ‬द ‫ڹ‬ɻ߃߁බཀྵָ෾໼֡ీɻ໎ඔ࿊‫ݱࣁܠ‬ཤ༽‫و৿ ܗ‬ιϱνʖௗ ߶‫ڰ‬ɻཤҲಊ෼ࣁ‫֋ݱ‬൅‫ڂݜ‬෾໼࡭Ԯɻय़๞෨ௗ೶ਈ‫֐ܨ‬Ռָ෾໼౽Ҭɻ߀ඛಝ೜०‫گ‬द ਭ໼ɻऴ৶ࡋ๖බସָ෾໼ࢀᅵɻ‫߃ي‬‫ڂݜ‬ҽঘ໼ɻຓҧࢢ೶࣮‫׳‬ඬຌࣁ‫ݱ‬մੵָ෾໼֡ీɻ໎ඔ‫ݗ‬౾೶ञ ͹‫ݬ‬ҾҪఽࢢรҡΝಝҡదͶཊ੏ͤΖVL51$֫࢐ҫ༂඾֋൅ϐφಝҡద͵೶ࡋ๖ͺՎͪ͢ͱ͍Ζ͹͖ʃεϱήϩιϩർֳφϧϱηέϨϕφʖϞʀΦϒΰόϞմੵ೶ਈ‫׳࣮۔ܨ‬ϠυϩϜΤηͶ͕͜Ζ௔գ৔ഋཝ༢ًॴཀྵͳൕ෰ࡀޮӻࡔ஄๑ਕࣰ‫ݩ‬ಊ෼஦ԟཝͶΓΖ‫ܧ‬౹ฯଚεητϞ͹֋൅‫ॶڂݜ‬࿊‫ݱࣁܠ‬ཤ༽‫ و৿ ܗ‬ਈ‫ࡋײܨ‬๖Ͳ͹ҪఽࢢรҡͶΓΖञ ԿϟΩωθϞ͹մੵ ࿊‫ݱࣁܠ‬ཤ༽‫ܩ ܗ‬କࣙષՌָ‫ߑؽڂݜ‬൅ୣ‫غ‬೶಼ඏࡋߑଆ͹ਫ਼ର΢ϟʖζϱήͶΓΖਈ‫ܨ‬յ࿑‫ܙ‬੔‫ؽ‬঄͹մ໎ ࿊‫ݱࣁܠ‬ཤ༽‫ܩ ܗ‬କ 7'3බรͶ݃߻ͤΖ෾ࢢϕϫʖϔ͹֋൅ࠅཱིබӅ‫ߑؽ‬୉ࡗҫྏιϱνʖ‫ۿ‬ຌ୉ָྖࢢՌָٗढ़‫֋ڂݜ‬൅‫ؽ‬ߑʀ๎ࣻતҫָ૱߻‫ॶڂݜ‬ۜଞɻธദ ࿊‫ݱࣁܠ‬ཤ༽‫ܩ ܗ‬କ ೶࣮‫׳‬ΰόϞ৚ๅͶ‫͚Ͱخ‬බସϠυϩϜΤη͹֋൅Ͷ‫ͤؖ‬Ζ‫ڂݜ‬ཀྵԿָ‫ॶڂݜ‬࣪ௗ٤໨ɻ५ಊ෼ࣁ‫֋ݱ‬൅‫ڂݜ‬෾໼࡭Ԯɻय़๞ ࿊‫ݱࣁܠ‬ཤ༽‫ܩ ܗ‬କ ิߨӣಊ͹୉೶‫خ‬ఊ֫χʖϏϝϱ੏‫ߑؽޜ‬͹մ໎୉ࡗ୉ָ०‫گ‬द໨௣ઔɻচ࢛ಊ෼ࣁ‫֋ݱ‬൅‫ڂݜ‬෾໼࡭Ԯɻय़๞౨‫ۂ޽ښ‬୉ָ‫گ‬दҲੋɻ޼ಊ෼ࣁ‫֋ݱ‬൅‫ڂݜ‬෾໼࡭Ԯɻय़๞ࠅཱིௗथҫྏ‫ڂݜ‬ιϱνʖ࣪ௗ໨ଞɻ଻೯බཀྵָ෾໼ଠీɻਇཀྵ‫౐ښ‬୉ָಝఈߪࢥߧઔɻ๗ٍබཀྵָ෾໼֡ీɻ໎ඔ‫ؖ‬੤ָӅ୉ָ‫گ‬द໾ඎɻүࢢಊ෼ࣁ‫֋ݱ‬൅‫ڂݜ‬෾໼࡭Ԯɻय़๞୉ࡗ୉ָঁ‫گ‬஦ਁɻկ೯බཀྵָ෾໼ੜਭɻ޼࣪ௗࠕଞɻಕദಊ෼ࣁ‫֋ݱ‬൅‫ڂݜ‬෾໼࡭Ԯɻय़๞୉ࡗ୉ָ‫گ‬दঘࢃ಼ɻࣰಊ෼ࣁ‫֋ݱ‬൅‫ڂݜ‬෾໼࡭Ԯɻय़๞౨‫ښ‬୉ָঁ‫گ‬౤ଡɻඔุࢢබཀྵָ෾໼֡ీɻ໎ඔ๼཮୉ָ‫گ‬दࠦ౽ɻय़࠺ಊ෼ࣁ‫֋ݱ‬൅‫ڂݜ‬෾໼࡭Ԯɻय़๞ ࿊‫ݱࣁܠ‬ཤ༽‫ܩ ܗ‬କϠόΠϝϱਈ‫ఽܨ‬ୣ෼࣯߻੔‫ؖ‬࿊Ҫఽࢢ͹ૌ৭ಝҡదഃշͶΓΖਫ਼ཀྵ‫ؽ‬೵รԿ͹մੵ ࿊‫ݱࣁܠ‬ཤ༽‫ܩ ܗ‬କ ϝέϫήϨΠ‫ؽ‬೵ΝൕӫͤΖ3(7΢ϟʖζϱή͹֋൅ ࿊‫ݱࣁܠ‬ཤ༽‫ܩ ܗ‬କ ࿊‫ݱࣁܠ‬ཤ༽‫ܩ ܗ‬କ೶ώϱέ‫ݗ‬ରΝ༽͏ͪՅྺͶ൒͑೶ૌ৭͹έϫʖϱ࠸ߑ੔‫;ٶ‬೶ञ ൅ਫ਼Ͷ‫ͤؖ‬Ζ‫ڂݜ‬ਈ‫ܨ‬ૌ৭ಝҡద6FUDSSHUόρέΠΤφϜΤη͹ࡠड़ͳਈ‫ܨ‬ร੓Ͷ‫ͤؖ‬Ζմੵ࿊‫ݱࣁܠ‬ཤ༽‫ܩ ܗ‬କ ‫ک۔‬௜੓ζηφϫϓΡʖ͹஦਽ਈ‫ܨ‬බସ͹մ໎࿊‫ݱࣁܠ‬ཤ༽‫ܩ ܗ‬କ ζηφϫϓΡϱ݃߻νϱϏέ࣯෵߻ର͹େःյ఺Ͷ‫ͤؖ‬Ζ‫ڂݜ‬࿊‫ݱࣁܠ‬ཤ༽‫ܩ ܗ‬କ ೶ʀਈ‫ܨ‬յ࿑Ͷ͕͜ΖχʖϏϝϱ͹‫ؽ‬೵մੵ࿊‫ݱࣁܠ‬ཤ༽‫ܩ ܗ‬କ࿊‫ݱࣁܠ‬ཤ༽‫ܩ ܗ‬କ‫ޛ‬෨ࢻজԾ෨Ͷ͕͏ͱգເ঳Ͷ‫ؖ‬࿊ͤΖ'1$ϟοϩԿ෨Ғ͹୵ࡩͳ֦೶྘ҮͶಝҡద͵ϟοϩԿϕϫϓΟ΢ϩ͹୵ࡩ
7'3ࡋ๖಼‫ࡑۃ‬η΢ρο੏‫ޜ‬ͶΓΖ‫۔‬Ҧक़੓ଈࡩߙԿ঳Ϡυϩ͹ࡠ੔ˠॶ଒͕Γ;৮໌ͺਅ੧࣎͹΍͹Ͳͤɽࠅཱི੠ਈʀਈ‫ܨ‬ҫྏ‫ڂݜ‬ιϱνʖList of Global Collaborative Research Project FY2020, Brain Research Institute, Niigata University
New
Project #Principal Investigator

BRI Host Collaborator

Project Title
Affiliation

Renew

Production of congenital nystagmus model miceand analysis of visual function

Position

Name

Dept

Name

Keisuke Yonehara

Comparative &Experimental
MedicineToshikuni
Sasaoka

Prof.

Marat
Mukhamedyarov

Pathology

AkiyoshiKakitaAssociate
Prof.

Tomonori Takeuchi

Animal Model
Development

Manabu Abe

Department of Pathology, Johns Hopkins Associate
University School of Medicine, USA
Professor

Fausto J Rodriguez

Neurosurgery

Yukihiko Fujii

Departments of Psychiatry and Radiology
Prof.
/ Harvard Medical School, USAMarek Kubicki

Center for
Integrated HumanBrain ScienceHironaka
Igarashi

Associate
DANDRITE, Department of Biomedicine,Prof. / Group
Aarhus University, Denmark
Leader

1G3005Renew

2G3006Development of gene-cell therapy of Alzheimer’s
Renew disease based on delivery of neurotrophic factors Kazan State Medical University, Russia
to brain: translational study

3G3007Renew

4

G201902 Renew Role of autophagy in NF1-associated gliomas

5G201903 Renew

6G202001

New Hydrodynamic Pathology of the Brain

Neurology, Univ. of California Davis, USA Prof.

Ingrid L Kwee

Center forIntegrated Human
Brain Science

Hironaka
Igarashi

7G202002

Elucidating the role of SLFN11 in response to
New PARP inhibition in diffuse intrinsic pontine
gliomasDivision of Pediatric Oncology
Sidney Kimmel Comprehensive Cancer
Center, Johns Hopkins School ofMedicine, USA

Associate
Prof.

Eric H. Raabe

Neurosurgery

Yukihiko Fujii

8G202003

Computational quantitative analysis for
New neuropathologic feature of α-synucleinopathy
patients

Clinical
Department of Pathology, Asan Medical
AssistantCenter, Seoul, Republic of Korea
Prof.

Soo Jeong NamPathology

AkiyoshiKakita

9G202004

The role of striatal direct and indirect pathways
New and dopamine D2 isoforms in thepathophysiology of psychosis

Department of Pharmaceutical Sciences,
Ben and Maytee Fisch College ofAssociate
Pharmacy, The University of Texas atProf.
Tyler, USA

Yanyan Wang

Comparative &Experimental
MedicineToshikuni
Sasaoka

Hiroshi Ito

Cellular
Neuropathology

Takayasu
Mikuni

Assessing molecular mechanisms of noveltyinduced memory boost by using geneticallymodified rats derived from embryonic stem cellline for Lister-hooded rat

Development, optimization and validation ofhuman AQP-4 PET Radioligand

Department of Biomedicine, Aarhus
University, Denmark

10 G202005

Investigation of the role of neuromodulators inMax Planck Institute for Brain Research, Research
New state transition of neural dynamics to represent aGermany
Group Leader
behavioral goal

11 G202006

New

Investigating the role of BAI1 in the tumor cell
invasion of malignant glioma

Department of Neurosurgery, School of
Medicine and O’Neal Comprehensive
Assistant
Cancer Center, University of Alabama at Prof.
Birmingham, USA

Satoru Osuka

Neurosurgery

Yukihiko Fujii

12 G202007

New

Investigation of pathogenesis of Alzheimer’s
disease using mouse models

Dept. Neurobiology, Univ. ofAssistantMassachusetts Medical School, Brudnick
Prof.
Neuropsychiatriy Research Institute, USA

Kensuke Futai

Comparative &ExperimentalMedicine

Toshikuni
Sasaoka

13 G202008

Establishing the Neurodegenerative Pathologic
New Diagnostic Protocols by Intensive Pathologic
Reviews

Department of Pathology, College ofMedicine, Inje University Busan Paik
Hospital, Republic of Korea

Hwa Jin ChoPathology

AkiyoshiKakitaAssistantProf.